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Abstract 
Objective To investigate the effectiveness of a six-week exercise programme in patients 
discharged home following critical illness compared to standard care. 
Design Multicentre prospective phase 2 randomised controlled trial, with blinded outcome 
assessment after hospital discharge, following the six week intervention and at six months. 
Participants 60 patients (30 per group) aged ≥18 years, mechanically ventilated >96 hours, 
and not in other rehabilitation i.e. cardiac or pulmonary rehabilitation programmes. 
Participants in the intervention group completed an individually tailored (personalised) 
exercise programme. 
Outcome measures Primary outcome measure was SF-36 physical functioning following the 
intervention. Secondary outcomes included a range of performance-based and patient-
reported measures. 
Results Improvements in the primary outcome did not differ significantly between groups 
(mean difference [95%CI] 3.0 [-2.2, 8.2], p=0.26). The intervention group showed significant 
improvement compared to the control group (mean difference [95%CI]) in: SF-36 role 
physical (6.6 [0.73,12.5], p=0.03); Incremental shuttle walk test (83.1m [8.3,157.9], p=0.03); 
Functional limitations profile (-4.8 [-8.7,-0.9], p=0.02); self-efficacy to exercise (2.2 [0.8,3.7], 
p=0.01) and readiness to exercise (1.3 [0.8,1.9], p<0.001). These improvements were not 
sustained at six months except readiness to exercise. Improvements in all other secondary 
outcome measures were not significant. 
Conclusions There was no statistically significant difference in the primary outcome measure 
of self-reported physical function following this 6 week exercise programme.  Secondary 
outcome results will help inform future studies. 
Trial registration number NCT01463579 (ClinicalTrials.gov). 
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For the trial protocol see http://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-
15-146  
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INTRODUCTION 
Globally it is recognised that there is an urgent need to investigate interventions which could 
improve outcomes of patients after critical illness. It is estimated in the UK that 
approximately 100,000 patients who are admitted to critical care annually survive to hospital 
discharge. These patients suffer from reduced physical function, exercise capacity, health-
related quality of life and increased healthcare utilisation, which may continue for up to five 
years following discharge home from hospital.[1,2] 
 
Studies investigating rehabilitation following critical illness have increased in recent years. 
However there remains limited evidence  to support rehabilitation following discharge from 
hospital for patients who survive critical illness as current studies show discordant results.[3-
11] Current guidelines in the UK [12] highlight the lack of high quality evidence to inform the 
appropriate timing and intervention for rehabilitation following critical illness. Further 
research is needed to inform the development of evidence based guidelines for practice in line 
with other clinical populations where rehabilitation has been proven to be effective.[13] 
 
The primary aim of this trial was to investigate the effectiveness of an individually tailored 
(personalised) six-week exercise programme on physical function in patients discharged from 
hospital following critical illness compared to standard care. Secondly, we aimed to 
investigate the effectiveness of the six week programme of exercise on exercise capacity, 
health-related quality of life, anxiety and depression, and self-efficacy and readiness to 
exercise in patients discharged from hospital following critical illness compared to standard 
care; to determine the feasibility (safety, practicality and acceptability) of providing a six-
week programme of exercise for patients discharged from hospital following critical illness; 
and to explore the medium-term (six-months) effects of the exercise programme. 
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METHODS 
 
Design 
The study protocol has been described previously.[14] In brief, this multicentre prospective 
phase 2, allocation-concealed, assessor-blinded, randomised controlled clinical trial (RCT) 
investigated the effectiveness of a six-week personalised programme of exercise on patient 
outcomes following discharge from hospital after critical illness compared to standard care. 
Ethical approval was obtained from the Northern Ireland Research Ethics Committee 
(11/NI/0115). The Northern Ireland Clinical Trials Unit (CTU) supported the conduct of the 
trial. The reporting of this trial adheres to the Consolidated Standards of Reporting Trials 
statement for randomised controlled trials (CONSORT)[15] and the Template for Intervention 
Description and Replication (TIDieR).[16] 
 
Participants 
Participants were recruited from general intensive care units (ICUs) in six hospitals in 
Northern Ireland, UK. Eligible patients were aged ≥18 years, had received mechanical 
ventilation for >96 hours, were planned to be discharged home, were medically fit to 
participate and were not participating in another rehabilitation programme i.e. cardiac 
rehabilitation or pulmonary rehabilitation. All patients gave informed consent to participate. 
Patients were randomly assigned to groups in a 1:1 ratio with the use of permuted blocks. 
Variable block sizes were used to ensure blinding. The randomisation schedule was generated 
using nQuery Advisor and allocations were done centrally online by the CTU which is located 
external to the study sites (allocation concealment). 
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Intervention (exercise programme) 
The intervention group received standard care and completed a personalised exercise 
programme which consisted of two supervised and one unsupervised exercise session/s per 
week for six weeks. The exercise programme was planned to take 6 weeks to complete, 
however, could be delivered over approximately 10 weeks to allow for participant non-
attendance. Outpatient supervised sessions took take place in the hospital gymnasium, or if 
this was not possible, in the participant’s home and unsupervised sessions took place at home. 
The programme was delivered by a trained physiotherapist who worked closely with the 
critical care team. Physiotherapists’ skills in exercise prescription, clinical reasoning and 
knowledge of the patient population facilitated the personalised nature of the programme. In 
addition, physiotherapists delivering the programme completed standardised training 
procedures and received a comprehensive intervention training pack including examples of 
how exercises could be personalised and progressed. The contents index of the training pack 
is included in the online supplement. 
 
The exercise sessions consisted of (i) a warm-up period, (ii) a circuit of 10 arm, leg and whole 
body conditioning and strengthening exercises, (iii) an additional period of aerobic exercise 
(for example walking, cycle ergometry or treadmill walking for at least 10 minutes and 
progressing as able up to a maximum of 30 minutes) to maintain moderate breathlessness, and 
finally (iv) a cool down period and relaxation. The sessions lasted a maximum of 1 hour. 
Hand strengthening and dexterity exercises were also incorporated within the exercise 
sessions. Exercises were progressed to maintain a level of moderate breathlessness (3-4 Borg 
Breathlessness Scale). Strengthening exercises were included, using higher repetitions and 
sets and an increase in weight for progression. The aerobic exercise was based e.g. on the 
patient’s heart rate and/or the results of the Incremental Shuttle Walk Test (ISWT) measured 
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at baseline assessment. Participants were provided with an exercise manual (available from 
http://www.science.ulster.ac.uk/inhr/revive-manual.pdf). The manual contained standardised 
descriptions and pictures of the exercises alongside space for the physiotherapist to document 
details of personalisation of the programme. 
 
Protocols to manage patient safety were followed. There was a medical screening process to 
determine medical suitability of participants for the trial and then to review the status of each 
patient just prior to the baseline assessment to confirm safety to participate. The 
physiotherapist also determined the suitability of the participant to start and progress the 
exercises prior to and at their first appointment and at subsequent appointments through 
review of baseline information, medical notes, consultation with a designated research team 
member (and critical care consultant if needed), and clinical assessment. Modifications were 
implemented when indicated, for example, for an abdominal crunch if a patient was unable to 
adopt a supine position the abdominal muscles were engaged by modifying this exercise to a 
seated position. Examples of such modifications, and condition specific fact sheets and 
protocols e.g. for diabetes and cardiac conditions were available to the physiotherapist as part 
of their intervention training pack.  
 
Strategies to optimise treatment fidelity and ensure the intervention was delivered as intended 
were included, such as weekly phone calls with the research team to discuss individual patient 
treatment plans, and regular training updates.[17] Participants allocated to the intervention 
commenced the programme as soon as possible following baseline assessment. Participants 
allocated to the standard care group received no additional support after hospital discharge. 
 
Data collection and procedures 
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Blinded outcome assessment was performed prior to randomisation at baseline (visit 1) 
(ideally within two weeks of hospital discharge or when the patient was deemed medically fit 
and/or able to attend), at visit 2 (following completion of the six week intervention) and at 
visit 3 (six months following randomisation). Assessment was carried out by Northern Ireland 
Clinical Research Network research nurses independent of the research team and who were 
blinded to group allocation. Participants were instructed not to discuss their group allocation 
with the blinded outcome assessor. 
 
Outcome Measures 
The primary outcome measure was physical function (change from baseline) as measured by 
the physical functioning (PF) subscale of the SF-36 Health Survey at visit 2 (following 
completion of the six week intervention, or equivalent time points for the standard care 
group).[18] Secondary outcome measures included a range of patient-reported and 
performance-based measures at six weeks and 6 months (Table 1). 
 
Table 1 Secondary outcome measures 
 Outcome measure 
Physical function Rivermead mobility index (RMI) [19] 
Hand function (strength and 
dexterity) 
Hydraulic hand dynamometer [20] 
Nine hole peg test [21] 
Exercise capacity Incremental shuttle walk test (ISWT) [22] 
Health-related quality of life Remaining SF-36 Health Survey subscales and component 
summary scores [18] 
Functional Limitations Profile (FLP) [23] 
EuroQol-5D-5L [24] 
Breathlessness MRC Dyspnoea scale [25] 
Anxiety and depression Hospital Anxiety & Depression Scale [26] 
Readiness to exercise Readiness to change questionnaire [27] 
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Self-efficacy to exercise Chronic disease self-efficacy scale (exercise component) 
[28] 
Footnote: Healthcare utilisation questionnaire and semi-structured interviews to assess cost 
effectiveness and patient views about the programme were also collected but not reported in 
this manuscript. These will be the focus of separate publications.  
 
Feasibility as determined by safety, practicality and acceptability of the intervention was 
assessed by collecting data on the occurrence of adverse events, recruitment and retention, 
and the delivery and adherence to the exercise programme. Adherence was defined a priori as 
completion of 75% of supervised exercise sessions or greater. At the beginning of the exercise 
programme participants were asked to set a personal functional goal. After the programme 
participants were asked to rate their confidence that they had achieved this on a numerical 
visual analogue scale (VAS). 
 
Statistical Analysis 
There was limited data available in this specific research area at trial inception in order to 
conduct a formal sample size calculation. Without adequate meaningful data available, it is 
useful to use a more general recognised method, the Cohen method.[29] Using this method, it 
was estimated that 52 patients (26 per group) would be required (Cohen’s [29] effect size of 
0.5).  On the basis of the previous experience of the research team a loss of 25% after 
randomisation [30] was anticipated and therefore we planned to recruit up to 68 participants 
(34 in each group), or until we achieved 52 (26 per group) completed datasets with the 
primary outcome measure at six weeks. Effectiveness of the intervention was analysed on an 
intention to treat basis. Standard approaches were used to detect patterns in missing data and 
imputation was performed using the group average. For the primary and other continuously 
distributed outcomes, differences between groups were tested using independent samples t-
tests or non-parametric equivalents. Adjustments were made for baseline outcomes, baseline 
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characteristics and other covariates as appropriate using analysis of covariance (ANCOVA). 
ANCOVA was also used to explore trends across time and differences between the groups. 
Chi-square tests (or Fisher’s Exact tests) were used for categorical variables. The change from 
baseline was calculated by subtracting the baseline values from follow-up values, with 
between group differences presented as means and 95% confidence intervals. Further 
information and exploratory subgroup analysis is detailed in the online supplement. 
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RESULTS 
 
Trial recruitment 
Recruitment occurred over a 3-year period from December 2011 until December 2014. Sixty 
participants (30 per group) were randomised. The participant flow through the trial is 
illustrated in Figure 1. Participant baseline characteristics were not significantly different 
between study groups, except for gender (Table 2). Baseline outcomes were significantly 
worse in the intervention group for SF-36 bodily pain (BP) and mental health (MH) subscales, 
Hospital anxiety and depression scale (HADS), Incremental shuttle walk test (ISWT), 
Functional limitations profile (FLP) psychosocial dimension and readiness to exercise (Table 
3). There was no significant difference between groups in the number of days following 
hospital discharge that participants attended Visit 1 assessment (Baseline) (44 (29) days 
(control group) and 49 (29) days (intervention group)). Visit 2 (six-week follow up) was 
completed by 55 participants (29 control group, 26 intervention group) and therefore the 
predetermined sample size was achieved. Visit 3 (six-month follow up) was completed by 49 
participants (27 control group, 22 intervention group). There were no significant differences 
between groups in the time from Visit 1 to Visit 2 or from Visit 1 to Visit 3 (Table 2).
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Table 2 Participant baseline characteristics of intervention group and control group 
(Visit 1) 
Variable Intervention 
(N = 30)  
Control 
(N = 30)   
Age, yrs 51 (13) 51 (14) 
Gender 
   Male 
   Female 
 
13 [43] 
17 [57] 
 
21 [70] 
9 [30] 
ICU primary diagnosis 
   Respiratory 
   Cardiovascular  
   Gastrointestinal 
   Neurological 
   Trauma 
   Genito-urinary 
   Other 
 
17 [56·7] 
4[13·3] 
3 [10·0] 
2 [6·7] 
2 [6·7] 
1 [3·3] 
1 [3·3] 
 
13[43·3] 
4 [13·3] 
6 [20·0] 
3 [10·0] 
3 [10·0] 
0 [0·0] 
1 [3·3] 
APACHE 2* 17·3 (7·7) 15·2 (5·6) 
 
Length of stay in ICU, days 
Median (IQR) 
16·0 (8.0, 21·5) 
Median (IQR) 
13.0 (9.8, 23.8)  
Duration of mechanical 
ventilation, hrs 
293·6 (269·8) 311·9 (235·8) 
 
Length of stay in hospital, days 
Median (IQR) 
27·5 (18·8, 46·3) 
Median (IQR) 
32·5 (20.8, 53.8)  
Living alone                                             5 (16·7) 7 (23·3) 
Time between hospital 
discharge & Visit 1 (baseline), 
days 
48·9 (29·4) 44·3 (28·6) 
Time between Visit 1 (baseline) 
& Visit 2 (6 weeks), days 
78.19 (26·6) 73·3 (21·0) 
Time between Visit 1 (baseline) 
& Visit 3 (6 months), days 
191·8 (26·6) 183·1 (20·6) 
Values are mean (SD) or Number [%] unless stated 
*APACHE 2: Acute Physiology And Chronic Health Evaluation 2 score 
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Table 3 Participant baseline outcomes of intervention group and control group (Visit 1) 
Variable Intervention 
n = 30 
Control 
n = 30 
SF-36* 
  Physical functioning (PF) 
  Role physical (RP) 
  Bodily pain (BP) 
  General health (GH) 
  Vitality (VT) 
  Social functioning (SF) 
  Role emotional (RE) 
  Mental health (MH) 
  Physical component summary (PCS) 
  Mental component summary (MCS) 
 
29·0 (11·0) 
31·3 (7·2) 
37·7 (10·3) 
38·1 (10·9) 
37·9 (10·1) 
29·7 (13·5) 
34·9 (12·9) 
38·3 (14·7) 
33·0 (8·0) 
38·0 (14·1) 
 
31·1 (9·6) 
30·4 (6·6) 
44·2 (10·9) 
42·2 (9·0) 
42·1 (9·7) 
33·9 (13·4) 
39·7 (14·2) 
46·2 (11·0) 
34·0 (8·0) 
45·0 (12·8) 
Rivermead mobility index (RMI)† 10·9 (3·5) 11·8 (2·7) 
 
Incremental shuttle walk test (ISWT)‡ 
  n=28 
166·1 (134·0) 
  n=28 
258·6 (171·7) 
Functional limitations profile (FLP)§ 
  Physical dimension 
  Psychosocial dimension 
  Overall score 
 
28·0 (16·7) 
29·6 (21·2) 
26·8 (15·3) 
 
21·2 (15·8) 
19·5 (14·8) 
19·7 (12·3) 
EuroQol-5D-5L 
  Visual analogue scalell 
  Index** 
 
61·6 (18·8) 
0·5 (0·3) 
 
60·3 (18·3) 
0·6 (0·2) 
Hand held dynamometry†† 
  Dominant hand 
  Non-dominant hand 
 
60·4 [31·2] 
58·5[34·7] 
  n=29 
66·9 [20·1] 
67·4 [21·9] 
Nine hole peg test‡‡ 
  Dominant hand 
  Non-dominant hand 
   
75·9 [16·1] 
77·2[14·3] 
  n=29 
79·0 [13·4] 
77·6 [15·0] 
Hospital anxiety & depression scale 
(HADS)§§ 
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  Anxiety 
  Depression 
10·5 (5·4) 
7·6 (4·9) 
6·7 (4·2) 
5·1 (3·3) 
 
MRC dyspnoea scale,llll 
Median (IQR) 
 
3·0 (2·0,3·3) 
  Median (IQR) 
n=29 
2·0 (1·5,3·0) 
Chronic disease self-efficacy scale 
(exercise component) **** 
 
5·3 (2·5) 
 
6·3 (2·2) 
Readiness to exercise†††† 
  Pre-contemplation 
  Contemplation 
  Preparation 
  Action 
  Maintenance 
 
1 [3·3] 
15[50] 
11 [36·7] 
2 [6·7]  
1 [3·3] 
 
0 [0] 
9 [30] 
7 [23·3] 
9 [30] 
5 [16·7] 
Values are mean (SD) or Number [%] 
*SF-36 scores are calculated from norm-based scores for a UK population with a mean of 50 and SD 
10. A higher score represents better health-related quality of life (self-reported); 
†RMI range is 0-15 with a higher score indicating better physical function (self-reported and 
performance-based); 
‡ISWT range is 0-1020m with a higher distance indicating better exercise capacity (performance-
based); 
§FLP range is 0-100 with a lower score indicating better health-related quality of life (self-reported); 
llVisual analogue scale  range is 1-100 with a higher score indicating better health-related quality of 
life (self-reported); 
** Index score is derived from value sets for a UK population with a lower score indicating better 
health-related quality of life (self reported); 
††Percentage predicted score is calculated from norm-based UK values based on age and gender, [20] 
(performance based); 
‡‡Percentage predicated score is calculated from norm-based UK values based on age and gender, [21] 
(performance based); 
§§ HADS range is 0-21 with a higher score indicating a higher risk of anxiety/depression (self-
reported); 
llllRange is 1-5 with higher scores indicating greater disability due to breathlessness (self-reported); 
****Range is 1-10 with a higher score indicating better self-efficacy to exercise (self-reported); 
††††Each stage corresponds to the participants motivational readiness to exercise (self-reported). 
 
Delivery of the intervention 
The intervention was adhered to by 21 out of 30 participants (70%) (i.e. participants attended 
75% or greater of the intervention sessions according to the a priori definition of adherence). 
Reasons for non-adherence included: unable to contact the participant (n=3); exacerbation of 
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asthma (n=1); cancellations due to other commitments (n=1); and no longer wishing to 
continue the intervention (n=4). 
 
The time taken to complete the intervention ranged from six to 11 weeks. Participants who 
took longer than six weeks to complete the exercise programme had cancellations due to 
general health issues such as feeling unwell, medical issues, family commitments or clinical 
appointments. One participant missed appointments due to relapse of alcohol dependence.  
 
The intervention was designed to be group based over six weeks but due to the recruitment 
rate and the distance between the trial sites the majority of supervised sessions were 
conducted individually. The majority of participants were willing to attend the hospital for all 
of their supervised exercise sessions. No participant required exclusively home visits for the 
exercise programme. Home visits were necessary in five participants on at least one occasion 
and otherwise all attended as outpatients. The main reasons for home visits in these 
participants were due to participants reporting they felt too acute to attend the hospital, travel 
distance too great to tolerate, and unwilling to leave the house due to low mood. 
 
At the end of the programme participants rated their confidence (VAS 1 – 10) in achieving 
their pre-set personal functional goal as high (mean (SD), 9(1)). The majority (>80%) of the 
planned components of the intervention were adhered to when cross checked against the 
exercise case report form completed by the physiotherapist at each session, thus indicating a 
degree of high fidelity.[17] Further information relating to the delivery of the intervention 
including key components of fidelity is given in the online supplement. 
 
Primary outcome - physical function 
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For the primary outcome measure (SF-36 PF), improvement from Visit 1 (Baseline) to Visit 2 
(6 weeks) did not differ significantly between groups: mean difference 3.0 (95% CI -2.2 to 
8.2), p=0.26 (Table 4). This difference in favour of the exercise group was equal to the 
minimal clinically important difference (MCID) reported for the general population.[31] The 
primary outcome was missing for 8% of the participants. In order to adhere to the intention to 
treat principle, imputation (group average) was performed on the primary analysis but the 
result remained non-significant (p=0.30). 
Secondary outcomes 
The intervention group showed statistically significant improvement compared to the control 
group in the following secondary outcomes: SF-36 role physical (RP): mean difference 6.6 
(95% CI 0.73 to 12.5), p=0.03; ISWT: mean difference 83.1m (95% CI 8.1 to 157.9), p=0.03; 
FLP (overall score): mean difference -4.8 (95% CI -8.7 to -0.9),p=0.02, Chronic disease self-
efficacy scale (self-efficacy to exercise):  mean difference 2.2 (95% CI 0.8 to 3.7), p=0.01; 
and readiness to change questionnaire (readiness to exercise): mean difference 1.3 (95% CI 
0.8 to 1.9), p<0.001) (Table 4). The difference in the improvement in SF-36 RP and ISWT in 
favour of the exercise group were also above the MCIDs reported in other populations.[22, 
31] Improvements in the remaining secondary outcome measures (remaining SF-36 subscales 
and component summary scores; RMI; EuroQol-5D-5L; Hand held dynamometry; Nine hole 
peg test; HADS; and MRC dyspnoea scale) did not differ significantly between groups (Table 
4). The difference in the improvement in the SF-36 physical (PCS) and mental component 
summaries (MCS), and all SF-36 subscales apart from general health (GH) and mental health 
(MH) in favour of the exercise group were above the MCIDs reported in the general 
population.[31] Imputation analysis was also performed on secondary outcomes, which 
resulted in some additional secondary outcomes (SF-36 social functioning subscale (SF), SF-
36 Physical component summary) (PCS), and FLP physical dimension) moving from non-
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significant to significant. These results as well as additional FLP category scores are detailed 
in the online supplement. 
 
Table 4 Outcome variables for intervention group and control group: mean (SD) change and 
mean difference (95% confidence interval) from Visit 1 (Baseline) (Visit 2 minus Visit 1) 
Outcome Measure Intervention 
n = 26  
Mean (SD) 
change 
Control 
n = 29   
Mean (SD) 
change 
Difference mean 
change scores 
(95% CI) 
p-value 
SF-36a 
  Physical functioning (PF) 
  Role physical (RP) 
  Bodily pain (BP) 
  
  General health (GH) 
  Vitality (VT) 
  Social functioning (SF) 
   
  Role emotional (RE) 
  Mental health (MH) 
   
Physical component summary (PCS) 
 
Mental component summary (MCS) 
 
6·8 (10·9) 
12·0 (9·8) 
5·2 (9·1) 
 N=25 
0·43 (10·2) 
4·6 (10·1) 
10·7 (13·1) 
  N=25 
8·2 (14·5) 
2·8 (12·5) 
  N=25 
7·0 (7·8) 
  N=25 
5·8 (13·6) 
 
3·9 (8·2) 
5·4 (11·8) 
1·3 (8·5) 
 
-1·2 (7·8) 
2·3 (10·8) 
4·2 (12·3) 
 
2·5 (16·4) 
0·16 (11·7) 
 
3·2 (6·7) 
 
1·1 (13·1)   
 
3·0 (-2·2,8·2) 
6·6 (0·73,12·5) 
3·9 (-0·87,8·7) 
 
1·7 (-3·3,6·6) 
2·3 (-3·4,8·0) 
6·6 (-0·3,13·5) 
 
5·7 (-2·8,14·2) 
2·6 (-3·9,9·1) 
 
3·8 (-0·2,7·8) 
 
4·6 (-2·7,11·9) 
 
0·26 
0·03 
0·11 
 
0·50 
0·42 
0·06 
 
0·18 
0·43 
 
0·06 
 
0·21 
 
Rivermead mobility index (RMI)a 
  N=22 
1·3 (2·1) 
N=28 
1·1 (1·8) 
 
0·13 (-0·98,1·2) 
 
0·82 
 
Incremental shuttle walk test (ISWT)a 
  N=20 
135·5 (119·8) 
  N=25 
52·4 (126·7) 
 
83·1 (8·3,157·9) 
 
0·03 
Functional limitations profile (FLP)b 
  Physical dimension 
  Psychosocial dimension 
  Overall score 
  N=22 
-10·0 (9·7) 
-7·4 (12·3) 
-7·8 (7·4) 
  N=28 
-5·3 (7·5) 
-2·4 (9·2) 
-3·0 (6·3) 
 
-4·7 (-9·5,0·2) 
-5·0 (-11·1,1·1) 
-4·8 (-8·7,-0·9) 
 
0·06 
0·11 
0·02 
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EuroQol-5D-5L 
   Visual analogue scale (VAS)a 
   Indexb 
  N=22 
7·4 (20·4) 
0·02 (0·20) 
  N=28 
6·4 (17·9) 
0·02 (0·17) 
 
0·97 (-9·9,11·9) 
0·00 (-0·1,0·1) 
 
0·86 
0·998 
Hand held dynamometrya 
  Dominant hand 
  Non-dominant hand 
  N=22 
6·1 (28·1) 
9·1 (28·2) 
  N=26 
12·5 (22·8) 
14·0 (28·7) 
 
-6·4 (-21·2,8·4) 
-4·9 (-21·5,11·7) 
 
0·39 
0·56 
Nine hole peg testa 
  Dominant hand 
  
  Non-dominant hand 
  N=22 
9·4 (15·3) 
  N=21 
8·9 (13·7) 
  N=26 
5·3 (10·7) 
  N=27 
5·3 (16·1) 
 
4·1 (-3·4,11·7) 
 
3·6 (-5·2,12·4) 
 
0·28 
 
0·41 
Hospital anxiety & depression scale 
(HADS)b 
  Anxiety 
  Depression 
   
N=22 
-0·59 (3·6) 
-1·2 (4·4) 
   
N=28 
0·18 (3·3) 
0·36 (3·1) 
 
 
-0·77 (-2·7,1·2) 
-1·6 (-3·7,0·6) 
 
0·43 
0·15 
 
MRC dyspnoea scaleb 
  N=22 
-0·14 (0·94) 
  N=27 
0·00 (1·00) 
 
-0·14 (-0·7,0·4) 
 
0·63 
 
Chronic disease self-efficacy scalea 
  N=22 
1·6 (3·0) 
  N=28 
-0·57 (2·1) 
 
2·2 (0·8,3·7) 
 
0·01 
 
Readiness to exercisea 
  N=22 
1·1 (0·97) 
  N=28 
-0·21 (0·96) 
 
1·3 (0·8,1·9) 
 
<0·001 
aA positive change score represents improvement 
bA negative change score represents improvement 
 
 
 
 
For the Analysis of Covariance (ANCOVA) the following covariates were selected: SF-36 
MH, HADS anxiety and depression, ISWT and FLP psychosocial dimension. These were 
selected due to differences at baseline which were deemed to be clinically important. In 
addition it has been shown that patients with worse mental health report more physical 
limitations after adjustment for physical performance.[32] Adjusted results remained 
statistically significant apart from FLP (overall score), and the FLP body care and movement 
category. 
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The primary analysis was repeated excluding the six non-adherers in the intervention group 
(those attending less than 75% of sessions). The overall trend for the results remained the 
same, but the improvement in the intervention group was larger. Further information is 
detailed in the online supplement. 
 
Improvements in the outcome measures at Visit 2 were not sustained at the six-month follow 
up assessment (Visit 3) apart from readiness to exercise. This is described in more detail in 
Figures 2 to 6. 
 
There was one unexpected serious adverse event which was assessed to be related to the 
intervention. This was a hospital admission following a recurrent acute exacerbation of 
asthma associated with anxiety, occurring at home within 24 hours of the intervention. 
Further details on adverse events are provided in the online supplement. 
 
DISCUSSION 
 
This study of a six-week personalised exercise programme, initiated after discharge from 
hospital following critical illness, found  no statistically significant difference in the primary 
outcome measure of self-reported physical function. The exercise programme resulted in 
statistically significant improvements in important patient-reported and performance-based 
secondary outcomes. These improvements were not sustained at six months except for 
readiness to exercise. Improvements in all other secondary outcome measures were not 
significant. 
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Patients with a longer length of stay in ICU and duration of mechanical ventilation than the 
majority of previous studies were included in this study. This was based on the hypothesis 
that these patients were more likely to have persisting disability and therefore would benefit 
more from a rehabilitation intervention.[33] More robust approaches to identify patients for 
inclusion for rehabilitation are required, for example, those with higher degree of organ 
failure have also been associated with increased incidence and severity of ICU acquired 
weakness.  A recent study has identified that patients mechanically ventilated for one week or 
more can be stratified into four disability risk groups based on age, ICU length of stay and 
functional dependency seven days after ICU discharge [34]. These groupings may be useful 
for future patient selection for rehabilitation. Due to the complex nature of this population 
identification of patients for inclusion for rehabilitation is likely required to be based on 
individualised assessment taking into account these risk factors. 
 
For our primary outcome of self-reported physical function (SF-36 PF), the difference was not 
statistically significant between groups. The SF-36 PF has demonstrated significant benefits 
of exercise rehabilitation in only one other comparable study.[10] It is possible that the 
primary outcome measure selected might not have been sensitive enough to detect a 
difference in the intervention group, given it is not a disease specific measure. The SF-36 has 
gaps in areas that patients after critical illness have indicated are important.[35] Development 
of critical care specific outcome measures may be required and is the focus of a systematic 
review.[36] 
 
In the absence of a consensus for the most appropriate outcomes to use in this population and 
critical care specific outcomes,[35, 36] we included a range of self-reported and performance-
based outcome measures as well as measures of self-efficacy and behaviour change relating to 
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exercise in this population. The intervention group showed statistically significant 
improvements compared to the control group in some but not all secondary outcomes at six 
weeks, and therefore it is difficult to draw strong conclusions from these results, however 
findings may be useful in defining future studies. While some secondary outcome measure 
differences were above published MCIDs, it is acknowledged that MCIDs for all outcomes 
were not available in the literature and none have been established specific to the post critical 
care population. Validated field exercise tests such as the ISWT reflect functional exercise 
capacity and are recommended in other rehabilitation programmes. This study highlighted the 
benefit of using the ISWT as it demonstrated a clinically important and significant difference 
with the ISWT following the intervention, with an improvement of 83m. The FLP, is a 
measure of health-related quality of life to evaluate individuals with varying types of and 
degrees of dysfunction.[23] This FLP demonstrated a statistically significant effect of the 
exercise programme in this study, whereas in contrast the Rivermead mobility index 
(RMI)[19] appeared to demonstrate a ceiling effect. This is the first study to assess and 
demonstrate significant improvements in self-efficacy and behaviour change relating to 
exercise in this population with the Chronic disease self-efficacy scale (exercise 
component)[28] and readiness to change questionnaire (readiness to exercise)[27] following 
the intervention. We wanted to explore participant’s ability to change from not participating 
in exercise to exercising regularly as this represents a significant shift in their behaviour and 
may be important to include. 
 
Our supervised exercise programme ended at six weeks and the statistically significant 
improvements demonstrated in the outcome measures following the intervention were not 
sustained at six months.  It has been reported that the training effect from exercise in healthy 
people declines at a rate of 1% a week once training ceases.[37] Literature in other 
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populations has similarly demonstrated the need for maintenance to sustain the benefits 
following short term programmes.[38] As part of this trial we have explored our participants’ 
perceptions of the programme of exercise they indicated the need for support to continue 
exercise. 
 
Our physiotherapy led intervention included important elements previously shown to be 
effective for rehabilitation in other populations [37-39] and was delivered with high 
fidelity.[17] The intervention was standardised yet tailored to individual patient’s needs 
facilitating exercise prescription and progression and the personal functional goals of 
participants. This is important for the heterogeneous post critical care population.  
 
The exercise programme in our trial was supervised twice per week by trained 
physiotherapists with knowledge of sequelae after critical illness. Other studies with 
supervised programmes have demonstrated some benefit,[3, 5, 7] whereas a home based study 
which did not incorporate a high level of supervision was unable to demonstrate improved 
outcomes.[8] Supervision or support may be an important component of rehabilitation as it 
has been suggested that exercise can be difficult for people to perform without feedback about 
their performance, or help to modify and progress the exercises.[40]  
 
Our study has several limitations; only a small proportion of patients screened and survived to 
hospital discharge were recruited (7.8%) which has implications for generalisability of the 
findings, although this is similar to the recruitment rate in the other rehabilitation studies 
following hospital discharge in this population. [5,8] Identification of which patients will 
benefit most from an exercise intervention based on baseline status has not been yet explored 
in the critical care population. Our analysis adjusted for the most clinically important baseline 
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differences in order to minimise any impact on our results. We did not classify improvement 
based on level of ability at baseline e.g. ISWT distance or explore the speed of recovery in 
our study due to small numbers. This could be an important outcome for future trials, as 
exploratory analysis in a previous study showed that rate of change over time (exercise 
capacity) was greater in the intervention group.[6] 
 
A large proportion of patients were excluded due to attendance at other disease specific 
rehabilitation programmes such as pulmonary or cardiac rehabilitation; these existing 
rehabilitation pathways were given priority over entry to the study as we anticipated that these 
patients may have disease specific needs; for example, patients with COPD may need 
additional education and skills on inhaled therapies, which was not a feature of the REVIVE 
intervention but is a feature of pulmonary rehabilitation. Conversely features of our 
rehabilitation may not be included in pulmonary rehabilitation. This highlights the need to 
explore the primary rationale for rehabilitation and whether the optimum rehabilitation would 
be the REVIVE intervention with additional components added. 
 
Many patients were not medically fit to participate in the intervention or declined to participate in 
this study as they felt they had other health issues. It is possible that these patients were 
offered the intervention too early in their recovery when management of their other health 
issue was perceived as a priority, for example delayed wound healing. Both physical and 
psychosocial health contribute to long term disability and the absence of psychosocial or 
educational components in our intervention  may have reduced the effect.[10, 38] The small 
proportion of patients recruited and the distance between sites impacted on the plan for a 
group based approach as the majority of sessions were completed individually. While a group 
bonding effect may have occurred if sessions were completed in a group format, conversely 
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individualised delivery of the exercise intervention may be more appropriate for this 
heterogeneous population. The intervention ended at six weeks, and other than the short 
consultation at the final exercise session, there were no exercise maintenance strategies 
incorporated into the intervention. This may have contributed to the lack of sustained 
improvements at six months.  
 
It is also recognised that our intervention targeted one phase of rehabilitation after critical 
illness while guidelines advocate seamless rehabilitation across the continuum of critical care 
recovery pathway.[12] Nonetheless, research into interventions to support the immediate post 
hospital discharge period are required [11] and the results of our study support the need for a 
more flexible and personalised approach to commencing such an exercise programme. 
Targeting early modifiable risk factors, for example, depressive symptoms may improve long 
term outcomes of survivors of critical illness and may also optimise the rehabilitation 
programme.[41] The cost effectiveness of our intervention has not yet been explored; 
however, costs for the delivery of other out-patient based rehabilitation programmes have 
been estimated and shown to be cost effective.[42] 
 
CONCLUSIONS 
A six-week personalised exercise programme, initiated after discharge from hospital 
following critical illness, found no statistically significant difference in the primary outcome 
measure of self-reported physical function. There were encouraging significant improvements 
in some, but not all secondary outcome measures that may be used to inform future studies. 
Improvements were not sustained at six months after the exercise intervention had been 
discontinued. A larger multicentre, phase 3 clinical trial of personalised exercise rehabilitation 
that also includes other components such as psychological support and behaviour change 
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techniques and longer-term exercise maintenance strategies should be considered. 
Appropriate outcome measures for this population relevant to the goals of the rehabilitation 
should also be used in future trials.  
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Figure legends 
Figure 1. Screening, randomisation and follow up of participants 
 
Figure 2: Trend across time for SF-36 Physical Functioning (PF) for each group 
 
(An increase represents improvement) 
Figure 2 shows there was an increase in physical functioning across time in both groups, 
however this increase was not statistically significant between groups (0.79). The interaction 
between group and time was not significant (p=0.08) indicating a similar pattern in both 
groups. There was no significant change in mean PF from baseline to 6 weeks (p=0.26) and  
from baseline to 6 months (p=0.79) between the two groups. 
 
Figure 3: Trend across time for Incremental Shuttle Walk Test (ISWT) for each group 
 
(An increase represents improvement) 
Figure 3 shows there was an increase in incremental shuttle walk test across time in both 
groups, however this increase was not statistically significant between groups (p=0.33). The 
interaction between group and time was not significant (p=0.13) indicating a similar pattern in 
both groups. There was a significantly (p=0.03) larger increase in mean ISWT from baseline 
to 6 weeks in the intervention compared to control group but no significant difference from 
baseline to 6 months (p=0.16). 
 
Figure 4: Trend across time for Functional Limitations Profile (FLP overall score) for each 
group 
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 (A decrease represents improvement) 
Figure 4 shows there was a decrease in functional limitations profile across time in both 
groups, however this decrease was not statistically significant between groups (p=0.20). The 
interaction between group and time was significant (p=0.01) indicating a different pattern in 
the two groups. There was a significantly (p=0.02) larger decrease in mean FLP from baseline 
to 6 weeks in the intervention compared to control group but no significant difference from 
baseline to 6 months (p=0.81).  
  
Figure 5: Trend across time for Chronic Disease Self-Efficacy Scale (exercise component) for 
each group 
 
(An increase represents improvement) 
Figure 5 shows there was an increase in self-efficacy in the intervention group from baseline 
to 6 weeks but this was not maintained at 6 months. There was a decrease in self-efficacy 
across time in the control group. This resulted in a significant group*time interaction 
(p=0.04). There was a significantly (p=0.01) larger increase in self-efficacy from baseline to 6 
weeks in the intervention compared to control group but no significant difference from 
baseline to 6 months (p=0.08). 
 
Figure 6: Trend across time for Readiness to Change questionnaire (readiness to exercise) for 
each group 
 
(An increase represents improvement) 
Figure 6 shows there was an increase in readiness to exercise across time in the intervention 
group but minimal change in the control group. This difference resulted in a significant 
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group*time interaction (p=<0.001). There was a significantly (p<0.001) larger increase in 
readiness to exercise from baseline to 6 weeks in the intervention compared to control group 
which was sustained at 6 months (p=0.012).  
 
 
